Citations

Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4784 total record number 156 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 34 out of 479
4784 citations found

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Antigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown

Aydin, S;Pareja, J;Schallenberg, VM;Klopstein, A;Gruber, T;Page, N;Bouillet, E;Blanchard, N;Liblau, R;Körbelin, J;Schwaninger, M;Johnson, AJ;Schenk, M;Deutsch, U;Merkler, D;Engelhardt, B;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Sequential Switching Through IgG1 is Redundant for Allergic Reactivity and Memory to Allergens

Koenig, J;Wade-Vallance, A;Jiménez-Saiz, R;Bruton, K;Gadkar, S;Grydziuszko, E;Walker, T;Gordon, M;Waserman, S;Jordana, M;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Intragastric model of sensitization

    Mice were sensitized with either 3.75 mg All-Natural Smooth Peanut Butter (Kraft Heinz, Northfield, USA), 1 mg ovalbumin (OVA) (MilliporeSigma, A5378), or 1 mg 4-hydroxy-3-nitrophenyl (NP)-OVA (LGC Biosearch Technologies, N-5051-100) by oral gavage with 5 μg cholera toxin (List Biological Labs, 100B) in 0.5 ml PBS. …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Fatigue during acute systemic inflammation is associated with reduced mental effort expenditure while task accuracy is preserved

Lambregts, BIHM;Vassena, E;Jansen, A;Stremmelaar, DE;Pickkers, P;Kox, M;Aarts, E;van der Schaaf, ME;

Product: LIST™ HPT™ from Escherichia coli O113

  • 2.2. General session procedures

    We performed all LPS-related procedures as described previously (Jansen et al., 2022). We tested three participants simultaneously in one room at the Medium Care Unit of Radboudumc. Sixty to 90 min before LPS administration, we placed a radial artery catheter and antebrachial venous cannula to allow serial blood sampling, hemodynamic monitoring, and administration of fluids and LPS, respectively and these stayed in during the remaining of the test-day. In the 45 min prior to LPS administration, we administered hydration fluids (2.5% glucose / 0.45% sodium chloride) as a 1.5L prehydration bolus to reduce the risk of vasovagal collapse(van Eijk et al., 2004), and thereafter at a rate of 150 mL/h for the remainder of the experiment. Directly after prehydration, we administered a bodyweight-adjusted bolus dose of 1 ng/kg LPS (E. Coli-derived, Type O113, lot no. 94332B1; List Biological Laboratories) intravenously. Behavioural testing took place at three timepoints: 45 min before injection (S1), 2 h post injection (S2) and 5 h post injection (S3). Timing was based on previous studies showing that sickness symptoms and cytokines peak 1.5–2 h after LPS administration and are largely normalized 5 post-LPS administration (Kox et al., 2015, Leentjens et al., 2012). At S2, participants were able to perform behavioural tasks while cytokine levels and fatigue are still high (Draper et al., 2018). Participants filled out mood questionnaires each hour after LPS administration. Furthermore, we obtained blood samples at various timepoints prior to and following LPS administration (see below). …

    Product #9433 – GMP LPS Lipopolysaccharide List™ Hpt™ From Escherichia Coli Type O113

Cell Specificity of Manganese-enhanced MRI Signal in the Cerebellum

Rallapalli, H;Bayin, NS;Goldman, H;Maric, D;Nieman, BJ;Koretsky, AP;Joyner, AL;Turnbull, DH;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization

Taton, M;Willems, F;Widomski, C;Martin, C;Jiang, Y;Renard, K;Cogan, A;Necsoi, C;Ackerman, ME;Marchant, A;Dauby, N;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Diphtheria toxin (DT) administration

    Diphtheria toxin (DT) powder was purchased from List Biological Laboratories (Campbell, CA, USA) and dissolved in 0.9% sterile saline at 2 mg/ml of stock concentration and stored at −20◦C.
    Stock DT solution was further diluted into 1 µg/ml of working concentration before use. Neonatal mice received a single dose of either DT injection at the dosage of 5 ng/g body weight or 0.9% saline injection at P5 or P14 (Tong et al., 2015). The injection was made in the thigh muscle of the right hind leg. Following either saline or DT injection, mice were allowed to survive to the age of P27–35 before tissue collection.

    Product #150 – Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

Therapeutic effect of the total saponin from Panax Japonicus on experimental autoimmune encephalomyelitis by attenuating inflammation and regulating gut microbiota in mice

Wang, J;He, L;Wang, S;Zhao, H;Chen, J;Dong, Y;Yasen, S;Wang, L;Zou, H;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

  • … Serological responses specific to B. pertussis antigens were quantified by ELISA. High-binding microtiter plates were coated with PT (50 ng/well) (PT#180, LIST Biologicals), FHA (50 ng/well) (Enzo Life Sciences), or PRN (50 ng/well) (PRN#187, LIST Biologicals) as described in Boehm et al (52). …

    Product #180 – Pertussis Toxin from B. pertussis, Lyophilized in Buffer